152 related articles for article (PubMed ID: 37982602)
1. Outcomes of Pleural Space Infections in Patients With Indwelling Pleural Catheters for Active Malignancies.
Chang CH; Ost DE; Jimenez CA; Saltijeral SN; Eapen GA; Casal RF; Sabath BF; Lin J; Cerrillos E; Nevarez Tinoco T; Grosu HB
J Bronchology Interv Pulmonol; 2024 Apr; 31(2):155-159. PubMed ID: 37982602
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
[TBL] [Abstract][Full Text] [Related]
3. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
[TBL] [Abstract][Full Text] [Related]
4. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
6. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters.
Vial MR; Ost DE; Eapen GA; Jimenez CA; Morice RC; O'Connell O; Grosu HB
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):98-105. PubMed ID: 27058711
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
Smith D; Shaw H; Ryder T
Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
Thomas R; Piccolo F; Miller D; MacEachern PR; Chee AC; Huseini T; Yarmus L; Bhatnagar R; Lee HJ; Feller-Kopman D; Maskell NA; Tremblay A; Lee YCG
Chest; 2015 Sep; 148(3):746-751. PubMed ID: 25742001
[TBL] [Abstract][Full Text] [Related]
12. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
[TBL] [Abstract][Full Text] [Related]
13. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
14. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use.
Gilbert CR; Wilshire CL; Chang SC; Gorden JA
Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991
[TBL] [Abstract][Full Text] [Related]
15. tPA/DNase for Complicated Parapneumonic Effusions and Empyemas.
Maiga A; Pinkerman R; Deppen SA; Scruggs J; Mcguire P; Tarpley JL; Grogan EL
Am Surg; 2017 Dec; 83(12):1458-1459. PubMed ID: 29336772
[No Abstract] [Full Text] [Related]
16. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
18. A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients.
Narula N; Katyal N; Salem M; Avula A; Siddiqui A; Maroun R; Chalhoub M
Respir Med Case Rep; 2021; 34():101420. PubMed ID: 34354918
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
20. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
